Advances in biomimetic nanomaterial delivery systems: harnessing nature's inspiration for targeted drug delivery

被引:7
|
作者
Kang, Weiqi [1 ]
Xu, Zhe [1 ]
Lu, Haiying [1 ]
Liu, Siwei [1 ]
Li, Jianshu [2 ]
Ding, Chunmei [2 ]
Lu, Yongping [1 ]
机构
[1] Guangyuan Cent Hosp, Guangyuan 628000, Peoples R China
[2] Sichuan Univ, Coll Polymer Sci & Engn, State Key Lab Polymer Mat Engn, Chengdu 610065, Peoples R China
关键词
MEMBRANE-COATED NANOPARTICLES; POLYMERIC NANOPARTICLES; MAGNETIC NANOPARTICLES; CO-DELIVERY; THERAPY; TUMOR; FUNCTIONALIZATION; DOXORUBICIN; NANOCARRIERS; NANOSYSTEM;
D O I
10.1039/d4tb00565a
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
The properties of nanomaterials make them promising and advantageous for use in drug delivery systems, but challenges arise from the immune system's recognition of exogenous nanoparticles, leading to their clearance and reduced targeting efficiency. Drawing inspiration from nature, this paper explores biomimetic strategies to transform recognizable nanomaterials into a "camouflaged state." The focal point of this paper is the exploration of bionic nanoparticles, with a focus on cell membrane-coated nanoparticles. These biomimetic structures, particularly those mimicking red blood cells (RBCs), white blood cells (WBCs), platelets, and cancer cells, demonstrate enhanced drug delivery efficiency and prolonged circulation. This article underscores the versatility of these biomimetic structures across diverse diseases and explores the use of hybrid cell membrane-coated nanoparticles as a contemporary trend. This review also investigated exosomes and protein bionic nanoparticles, emphasizing their potential for specific targeting, immune evasion, and improved therapeutic outcomes. We expect that this continued development based on biomimetic nanomaterials will contribute to the efficiency and safety of disease treatment. The properties of nanomaterials make them promising and advantageous for use in drug delivery systems, but challenges arise from the immune system's recognition of exogenous nanoparticles, leading to their clearance and reduced targeting efficiency.
引用
收藏
页码:7001 / 7019
页数:19
相关论文
共 50 条
  • [41] Advances in coamorphous drug delivery systems
    Qin Shi
    Sakib M.Moinuddin
    Ting Cai
    ActaPharmaceuticaSinicaB, 2019, 9 (01) : 19 - 35
  • [42] Advances in rectal drug delivery systems
    Purohit, Trusha J.
    Hanning, Sara M.
    Wu, Zimei
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2018, 23 (10) : 942 - 952
  • [43] Advances in coamorphous drug delivery systems
    Shi, Qin
    Moinuddin, Sakib M.
    Cai, Ting
    ACTA PHARMACEUTICA SINICA B, 2019, 9 (01) : 19 - 35
  • [44] Targeted drug delivery systems for the intracellular delivery of macromolecular drugs
    Koning, GA
    Storm, G
    DRUG DISCOVERY TODAY, 2003, 8 (11) : 482 - 483
  • [45] Targeted drug delivery to the brain using chemical delivery systems
    Bodor, N
    MEDICINAL CHEMISTRY: TODAY AND TOMORROW, 1997, : 183 - 190
  • [46] Advances in Understanding the Role of Aloe Emodin and Targeted Drug Delivery Systems in Cancer
    Karatoprak, Gokce Seker
    Akkol, Esra Kupeli
    Yucel, Cigdem
    Acikara, Ozlem Bahadir
    Sobarzo-Sanchez, Eduardo
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2022, 2022
  • [47] Advances in the development of aptamer drug conjugates for targeted drug delivery
    Chen, Ke
    Liu, Bo
    Yu, Bo
    Zhong, Wen
    Lu, Yi
    Zhang, Jiani
    Liao, Jie
    Liu, Jun
    Pu, Ying
    Qiu, Liping
    Zhang, Liqin
    Liu, Huixia
    Tan, Weihong
    WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 2017, 9 (03)
  • [48] Advances in Bone-targeted Drug Delivery Systems for Neoadjuvant Chemotherapy for Osteosarcoma
    Li, Cheng-jun
    Liu, Xiao-zhou
    Zhang, Lei
    Chen, Long-bang
    Shi, Xin
    Wu, Su-jia
    Zhao, Jian-ning
    ORTHOPAEDIC SURGERY, 2016, 8 (02) : 105 - 110
  • [49] The potential of biomimetic nanoparticles for tumor-targeted drug delivery
    Li, Bowen
    Wang, Fei
    Gui, Lijuan
    He, Qing
    Yao, Yuxin
    Chen, Haiyan
    NANOMEDICINE, 2018, 13 (16) : 2099 - 2119
  • [50] Drug delivery advances - Conditions right for drug delivery systems to speed to market
    Kelly, EB
    GENETIC ENGINEERING NEWS, 2001, 21 (12): : 1 - +